Signaling pathways
-
BA5099 SalmeterolSummary: Salmeterol (GR33343X) is a potent selective human adrenergic receptor agonist. -
BA5100 YS-49Summary: YS-49 is an activator of (a downstream target of RhoA) and reduces RhoA/PTEN activation in 3-methylcholine-treated cells.
-
BA5101 LabetalolSummary: Labetalol (AH5158) is an orally active selective α1- and non-selective β-adrenergic receptor competitive antagonist. -
BA5102 ClonidineSummary: Agonists. -
BA5105 PronethalolSummary: Pronethalol ((±)-Pronethalo) is a non-selective beta-adrenergic antagonist.
-
BA5106 HydroxybupropionSummary: Hydroxybupropion is the main active metabolite of Bupropion and is metabolized primarily by CYP2B6.
-
BA5108 VibegronSummary: Vibegron (MK-4618) is a potent -
BA5109 BI-167107Summary: BI-167107 is a high affinity full agonist at beta2 adrenergic receptors.
-
BA5110 LubabegronSummary: Lubabegron is a potent beta-adrenergic receptor modulator.
-
BA5111 L-765314Summary: L-765314 is a potent, selective antagonist.